Nord/LB set a €45.00 ($52.33) price target on Draegerwerk AG & Co KGaA (ETR:DRW3) in a research report sent to investors on Friday, Borsen Zeitung reports. The brokerage currently has a sell rating on the stock.
DRW3 has been the subject of several other reports. Warburg Research set a €49.00 ($56.98) price objective on Draegerwerk AG & Co KGaA and gave the company a neutral rating in a report on Wednesday, October 16th. Deutsche Bank set a €46.00 ($53.49) price objective on Draegerwerk AG & Co KGaA and gave the stock a neutral rating in a research report on Wednesday, August 14th. HSBC set a €50.00 ($58.14) target price on Draegerwerk AG & Co KGaA and gave the stock a neutral rating in a report on Tuesday, November 5th. Independent Research set a €52.00 ($60.47) target price on shares of Draegerwerk AG & Co KGaA and gave the company a sell rating in a research report on Tuesday, November 19th. Finally, Hauck & Aufhaeuser set a €38.00 ($44.19) target price on shares of Draegerwerk AG & Co KGaA and gave the company a sell rating in a research report on Tuesday, November 19th. Four investment analysts have rated the stock with a sell rating and three have given a hold rating to the stock. Draegerwerk AG & Co KGaA currently has an average rating of Sell and an average target price of €46.14 ($53.65).
Shares of ETR DRW3 traded down €1.00 ($1.16) during trading hours on Friday, reaching €55.65 ($64.71). 12,711 shares of the stock were exchanged, compared to its average volume of 33,804. The firm has a market capitalization of $422.94 million and a price-to-earnings ratio of 38.49. The stock’s fifty day simple moving average is €54.97 and its 200 day simple moving average is €49.54. The company has a debt-to-equity ratio of 31.33, a quick ratio of 1.09 and a current ratio of 1.93. Draegerwerk AG & Co KGaA has a 52 week low of €38.32 ($44.56) and a 52 week high of €59.40 ($69.07).
Drägerwerk AG & Co KGaA develops equipment and solutions in the fields of medical and safety technology in Europe, Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care.
Featured Story: Why do earnings reports matter?
Receive News & Ratings for Draegerwerk AG & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Draegerwerk AG & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.